Searchable abstracts of presentations at key conferences on calcified tissues

ba0005ni2 | Abstract Presentations | ECTS2016

Circulating microRNAs in postmenopausal women with osteoporosis and vertebral fractures

Yavropoulou Maria , Anastasilakis Athanasios , Makras Polizois , Grammatiki Maria , Kotsa Kalliopi , Yovos John

Circulating microRNAs (miRNAs) are currently being investigated as novel biomarkers for osteoporosis and osteoporotic fractures. The aim of the present study was to investigate the differential expression of specific circulating micro RNAs known to regulate bone metabolism and homeostasis in postmenopausal osteoporotic women with and without vertebral fractures. For the analysis, miRNAs were isolated from the serum of 24 osteoporotic patients with at least one moderate vertebr...

ba0005p245 | Genetics and Epigenetics | ECTS2016

Circulating microRNAs in postmenopausal women with osteoporosis and vertebral fractures

Yavropoulou Maria , Anastasilakis Athanasios , Makras Polizois , Grammatiki Maria , Kotsa Kalliopi , Yovos John

Circulating microRNAs (miRNAs) are currently being investigated as novel biomarkers for osteoporosis and osteoporotic fractures. The aim of the present study was to investigate the differential expression of specific circulating micro RNAs known to regulate bone metabolism and homeostasis in postmenopausal osteoporotic women with and without vertebral fractures. For the analysis, miRNAs were isolated from the serum of 24 osteoporotic patients with at least one moderate vertebr...

ba0007p36 | (1) | ICCBH2019

ALPL gene mutation in a family

Vai Silvia , Broggi Francesca , Luisa Bianchi Maria , Ponti Emanuela , Mihalich Alessandra , Maria Di Blasio Anna

Introduction: The clinical diagnosis of mild forms of hypophosphatasia [HPP], a rare genetic bone disease, is often made in adulthood, on the basis of persistently low serum levels of alkaline phosphatase [ALP], often coupled with signs of poor bone/teeth mineralization.Case report: A 50-year-old male on treatment with vitamin D supplementation because of osteoporosis of lumbar spine (T-score –3.2) and femoral neck (T-score –2.4), was referred ...

ba0001pp66 | Bone development/growth and fracture repair | ECTS2013

The P2Y2 receptor restrains BMD during development

Syberg Susanne , Ellegaard Maria , Schwarz Peter , Jorgensen Niklas Rye

The P2Y2 receptor is a G-protein-coupled receptor and the natural ligands (ATP/UTP) strongly inhibit mineralized bone nodule formation by osteoblasts in vitro. We have earlier shown that overexpression of the P2Y2 receptor in vivo resulted in decreased bone mineral density (BMD), partially due to increased bone resorption, but also decreased formation (detected by serum bone markers and bone histomorphometry).This ...

ba0001pp285 | Muscle, physical activity and bone | ECTS2013

Prolonged botulinum toxin type A-induced muscle paralysis results in loss of bone mineral density and bone strength in young female rats

Ellegaard Maria , Syberg Susanne , Jorgensen Niklas Rye , Schwarz Peter

Transient paralysis by a single injection of botulinum toxin type A (Botox) in rodents has been shown to cause local bone loss of the affected leg. The animals regain function of the leg within 3–4 weeks and bone loss slowly recovers. The duration of the paralysis is dose-dependent. However, higher doses of Botox cause weight loss and decreased activity level.Aim of study was to investigate whether repeated injections of low-dose Botox could induce ...

ba0001pp388 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

The association of leptin: adiponectin ratio with bone in overweight and obese postmenopausal women

Chi Yi-Chih , Liu Pei-Yang , Spicer Maria , Ilich Jasminka

Leptin and adiponectin have an opposing relationship in circulation; leptin is higher and adiponectin lower in overweight/obese individuals, and vice versa. Studies showed that both leptin and adiponectin can be either beneficial or harmful to bone depending on the mode of action. The objective was to investigate the association of serum leptin:adiponectin ratio (L:A) with BMD of various skeletal sites and markers of bone turnover in overweight and obese postmenopausa...

ba0001pp389 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Serum leptin and adiponectin in overweight and obese postmenopausal women after the 6-month weight loss program and their relationship with BMD

Chi Yi-Chih , Liu Pei-Yang , Spicer Maria , Ilich Jasminka

The connection between osteoporosis and obesity is becoming a topic of increasing research. The adipocyte-secreted hormones, leptin and adiponectin, may be the mediators between adipose tissue and bone. The aim was to examine the changes in leptin and adiponectin with the weight and body composition (fat and lean mass) change during the 6-months weight loss program. Additionally, the relationship between two adipokines and BMD of various skeletal sites was also examined. Parti...

ba0001pp480 | Other diseases of bone and mineral metabolism | ECTS2013

Effect of polyphenolic compounds from Aronia melanocarpa berries on cadmium accumulation in the bone tissue

Brzoska Malgorzata M , Galazyn-Sidorczuk Malgorzata , Jurczuk Maria

Cadmium (Cd) is a toxic heavy metal characterized by strong cumulative properties in the human and animals’ organism. Although cadmium accumulation in the bone tissue is lower than in soft tissues such as liver and kidney, the bone-accumulated metal, even at low concentrations, can damage the bone tissue directly. Polyphenols are compounds possessing hydroxyl groups capable of binding divalent metals, including toxic metals, preventing their absorption from the gastrointe...

ba0002p6 | (1) | ICCBH2013

The relationship between bone health and body composition profile in patients with galactose metabolic disorders: implications for practice

Doulgeraki Artemis , Monopolis Ioannis , Deligianni Domna , Kalogerakou Maria , Schulpis Kleopatra

Objectives: To evaluate bone health and its possible correlations to body composition parameters in young patients with galactose metabolic disorders, aiming to suggest appropriate lifestyle interventions.Methods: We studied 22 patients, aged 5–16 years with galactose metabolic disorders, detected by neonatal screening. Fourteen suffered from classic galactosemia and eight from other galactose metabolic disorders (i.e. epimerase or galactokinase def...

ba0002p69 | (1) | ICCBH2013

sRANKL/OPG in children with idiopathic hypercalciuria

Pavlou Maria , Siomou Ekaterini , Cholevas Vasileios , Siamopoulou Antigone , Challa Anna

Objectives: To determine any relationship of serum concentrations of osteoprotegerin (OPG), sRANKL and sRANKL:OPG ratio with idiopathic hypercalciuria (IH) in children, as there is some evidence of increased bone resorption in these patients.Methods: In a prospective study, twenty four children of median age 6.5 years (range 2.3–16.4) with IH (five had urolithiasis and two nephrocalcinosis) were examined at the time of diagnosis and after 3 months o...